RESUMO
The article delves into the multifaceted landscape of exotic pet medicine in Europe, exploring the impact of Brexit, evolving legislation surrounding exotic pet keeping, and challenges posed by the COVID-19 pandemic and the cost-of-living crisis. Regulatory changes, particularly in veterinary medication use, are discussed alongside the emergence of corporate entities in the veterinary industry. The article also underscores the need for improved education in exotic pet medicine and postgraduate qualifications. Overall, it provides a comprehensive overview of the dynamic factors shaping the practice, regulation, and education of exotic pet medicine across European countries.
Assuntos
Animais Exóticos , COVID-19 , Medicina Veterinária , Animais , Europa (Continente) , COVID-19/epidemiologia , Animais de Estimação , SARS-CoV-2 , Humanos , União Europeia , Legislação VeterináriaRESUMO
This article provides an overview of the development of exotic animal medicine in Latin America (LATAM), highlighting its historical evolution, current evidence, and future considerations. The practice of exotic animal medicine began in the 1970s and 1980s. The lack of knowledge and scientific resources led to the extrapolation of veterinary care for exotic species from human and companion animal medicine. However, from the 21st century onwards, globalization and collaboration among veterinary professionals have allowed greater access to knowledge and techniques for the treatment of exotic species in LATAM.